Alpine Global Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-44,660
Closed -$828K – 266
2023
Q3
$828K Buy
+44,660
New +$505K 0.19% 61
2015
Q1
– Sell
-3,500
Closed -$546K – 545
2014
Q4
$546K Buy
+3,500
New +$646K 0.1% 239

Alpine Global Management's ICPT Position: Q4 2023 in Review

Alpine Global Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 44,660 shares — an estimated $828K sold.

Alpine Global Management first reported a position in ICPT in Q4 2014 and held it in 2 quarters. The position peaked at $828K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Alpine Global Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Alpine Global Management sold 44,660 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $828K.
  • Alpine Global Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2014 and held it in 2 quarters.
  • Alpine Global Management's Intercept Pharmaceuticals, Inc. position peaked at $828K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Alpine Global Management's 13F filing for Q4 2023, filed 12 Feb 2024.